- Home
- Companies
- north america
- clinical studies
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Food and Beverage
- Agriculture
- Air and Climate
- University / Academia / Research
- Manufacturing, Other
- Waste and Recycling
- Government
- Energy
- Water and Wastewater
- Soil and Groundwater
- Oil, Gas & Refineries
- Construction & Construction Materials
- Mining
- Defense
- Metal
- Pulp & Paper
- Publishing / Media / Marketing
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Aerospace & Air Transport
- Forestry & Wood
- Glassware
- Retail
- Packaging
- Plastics & Resins
- Real Estate
- Travel & Leisure
Clinical Studies Suppliers In North America
487 companies found
Premium
based inTampa, FLORIDA (USA)
Applied Physics Corporation has offered cleanroom foggers since 2001. We also offer portable foggers, CO2 Foggers, ultrapure foggers to visualize airflow and turbulence. Room sanitizers are used to decontaminate unwanted bio contamination from clean ...
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
based inBothell, WASHINGTON (USA)
Cerevast Medical, Inc. is a clinical-stage medical device company based in Bothell, Washington, USA. Leveraging our core expertise in the fields of ultrasound and microsphere technologies, we are committed to developing novel, first-in-class ...
When a blood clot or thrombus is formed, strands of fibrin anchor one red blood cell to another. It is these fibrin strands that form the lattice or structural matrix of the blood clot. The formation or deposition of these clots in the arterial ...
based inLouisville, COLORADO (USA)
Colibri Heart Valve LLC (“Colibri”) is a privately held medical device company that researches and develops novel, patent protected, structural heart technologies. Colibri was formed in 2010 and is located near Boulder Colorado. Through Colibri’s ...
Colibri recently initiated a clinical early feasibility study (EFS) which is an international prospective, non-randomized, single arm, open label, trial to assess early feasibility of the Colibri second-generation ...
based inDurham, NORTH CAROLINA (USA)
With a proven track record in scientific innovation and product development, Lumedica creates affordable light-based scientific and medical instruments that deliver accurate diagnostic results. The mission of Lumedica Inc. is to create affordable, ...
based inSan Carlos, CALIFORNIA (USA)
Developing live biotherapeutics to prevent and treat diseases of high unmet medical need. We leverage our deep knowledge of the human microbiome and its regulatory and developmental functions to develop live biotherapeutic products (LBPs) and ...
Siolta’s patient-centric platform leverages our internal expertise in microbiome data analysis, machine learning, anaerobic microbiology, and translational studies to rationally design and optimize multi-strain live ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
A majority of individuals with CD do not recover well under a GFD. Furthermore, there is still no effective means for monitoring the intestinal health of a recovering celiac other than an invasive biopsy and even that method is prone to interpretive ...
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
iStent inject® W is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate primary open-angle ...
based inMinneapolis, MINNESOTA (USA)
Relievant Medsystems is a privately held medical device company with headquarters in Minneapolis, MN. Based on two decades of research, we developed the Intracept Procedure — a minimally invasive procedure that targets the basivertebral nerve for ...
based inMountain View, CALIFORNIA (USA)
ClearLight Biotechnologies provides contract research and development services to pharmaceutical companies who seek to improve the efficacy of potential drug candidates. The company provides pharmaceutical, biotechnology, and academic researchers ...
based inMississauga, ONTARIO (CANADA)
Covalon Technologies Ltd. (Covalon) develops and commercializes proprietary technologies for major medical device manufacturers. Our partners include the top medical device companies, leaders in urology, wound care, vascular access, venture capital, ...
based inAtlanta, GEORGIA (US) (USA)
AventaCell BioMedical Co., Ltd. ('AventaCell') is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products ...
based inSouthampton, PENNSYLVANIA (USA)
ETC is specialized in simulated environments for training, testing, and research & development for a variety of niche markets worldwide. ETC’s global reach includes operational installations in over 90 countries, with offices in the US, Europe, ...
based inSeattle, WASHINGTON (USA)
window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary ...
based inAllentown, PENNSYLVANIA (USA)
Like many great inventions, LifeAire Systems was created as the result of a need. Kathryn C. Worrilow, Ph.D., a leading embryologist has spent over two decades researching the causes of positive and negative spikes in clinical outcomes in In Vitro ...
based inLogan Township, NEW JERSEY (USA)
In science, quality is everything. Whether you’re uncovering basic insights into the inner workings of biological systems or are on the front lines of developing the next generation of therapeutics or diagnostics, you want your results to stand the ...
based inBerkeley, CALIFORNIA (USA)
Indee Labs is developing a non-viral, intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes with minimal perturbation. The technology is used by global ...
Hydropore™ is a simple, scalable and efficient way to accelerate the discovery, development and manufacturing of gene-modified cell therapies (GMCTs) such as T cell immunotherapies. This novel, non-viral technology utilizes the ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
based inIselin, NEW JERSEY (USA)
Excelra (formally Excelra Knowledge Solutions), established in 2016, is a dynamic informatics company focused on accelerating drug discovery and development through advanced data analytics and integrative informatics services. The organization ...
Our integrated IT services and bioinformatics expertise accelerate drug discovery and improve patient outcomes through bespoke scientific application ...
based inCambridge, MASSACHUSETTS (USA)
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against ...
VE416 is an orally administered rationally-defined bacterial consortium candidate being developed for the potential treatment of food allergy. VE416 consists of clonal human commensal bacterial strains selected for their ability to suppress allergic ...
